Labajo, Kyle Charmaine .
HRN: 23-93-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2023
AZITHROMYCIN 500MG TABLET (TAB)
10/18/2023
10/20/2023
PO
500mg 3 Doses
OD
CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes